ArticleCell reports. Medicine2025

Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models.

Ksenija Slavic Obradovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.